Allied Market Research

2024

Corifollitropin Alfa Market

Corifollitropin Alfa Market Size, Share, Competitive Landscape and Trend Analysis Report by Type (Industrial Grade, Pharmaceutical Grade, Others) and by End User (Hospitals, Laboratories): Global Opportunity Analysis and Industry Forecast, 2023-2032

Select an option
Author's: | Roshan Deshmukh
Publish Date:

Get Sample to Email

Corifollitropin alfa is a hybrid follicle-stimulating hormone (FSH) molecule, which is used to treat infertility. This molecule when injected results in the development of a high number of metaphase II oocytes in women.

The major factor that contributes to the growth of the corifollitropin alfa market is the high incidence of infertility in young people due to various reasons such as polycystic ovary syndrome and blockage in fallopian tube. Moreover, rapid rise in the number of fertility clinics, growing awareness about infertility treating hormones among population, and technological advancements in the healthcare sector enhance the market growth. However, high-cost infertility treatments and stringent regulatory issues may hinder the market growth. The improvement in corifollitropin alfa efficacy for in vitro fertilsation by introducing novel techniques will further boost the market growth.

The corifollitropin alfa market is segmented on the basis of types, end user, and region. Based on type the market is segmented into industrial grade, pharmaceutical grade, and others. On the basis of end user, the market is classified into hospitals and laboratories. By geography, the market has been analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The key players that operate in this market include Merck & Co., Inc., Schering-Plough Corporation, Ferring B.V., and many more.

Key Benefits

  • The study provides an in-depth analysis of the market with current trends and future estimations to elucidate imminent investment pockets.
  • The report provides information about the current and upcoming trends in the market which helps determine prevailing opportunities.
  • Comprehensive analysis of factors that drive and restrict the growth of the market has been provided.
  • Identification of factors instrumental in changing the market scenario, rise in opportunities, and identification of key companies that can influence this market on a global and regional scale has been provided.
  • Key market players within the market have been profiled in this report and their strategies thoroughly analyzed, which help understand the competitive outlook of the global market.

Corifollitropin Alfa Market Report Highlights

Aspects Details
Corifollitropin Alfa Market By Type
By Type
  • Industrial Grade
  • Pharmaceutical Grade
  • Others
Corifollitropin Alfa Market By End User
By End User
  • Hospitals
  • Laboratories
Corifollitropin Alfa Market By Region
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (France, Germany, Spain, UK, Rest of Europe)
  • Asia-Pacific  (China, Japan, India, Australia, Rest of Asia-Pacific)
  • LAMEA  (Brazil, South Africa, Saudi Arabia, Rest of LAMEA)
Key Market Players
Key Market Players

Ferring B.V., Merck & Co., Inc., Schering-Plough Corporation

Loading Table Of Content...

Individual sections of the reports are available for purchase.
Would you like to see a breakdown of prices by section?

Corifollitropin Alfa Market

Global Opportunity Analysis and Industry Forecast, 2023-2032